We are live on
!
Find out more
Acadia Pharmaceuticals
ACAD
ACAD
340 hedge funds and large institutions have $3.67B invested in Acadia Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 46 funds opening new positions, 113 increasing their positions, 128 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
54% more call options, than puts
Call options by funds: $12.9M | Put options by funds: $8.35M
39% more first-time investments, than exits
New positions opened: 46 | Existing positions closed: 33
2% more funds holding
Funds holding: 334 → 340 (+6)
1.7% less ownership
Funds ownership: 98.33% → 96.63% (-1.7%)
12% less repeat investments, than reductions
Existing positions increased: 113 | Existing positions reduced: 128
17% less capital invested
Capital invested by funds: $4.44B → $3.67B (-$775M)
50% less funds holding in top 10
Funds holding in top 10: 6 → 3 (-3)
Holders
340
Holders Change
+6
Holders Change %
+1.8%
% of All Funds
4.19%
Holding in Top 10
3
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-50%
% of All Funds
0.04%
New
46
Increased
113
Reduced
128
Closed
33
Calls
$12.9M
Puts
$8.35M
Net Calls
+$4.53M
Net Calls Change
+$2.55M
Top Buyers
| 1 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$31.8M |
| 2 |
First Trust Advisors
Wheaton,
Illinois
|
+$25.7M |
| 3 |
Jane Street
New York
|
+$19.2M |
| 4 |
BlackRock
New York
|
+$19M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$16.2M |
Top Sellers
| 1 |
TECP
Trails Edge Capital Partners
Atlanta,
Georgia
|
-$37.9M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$19.1M |
| 3 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
-$18.7M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$17.8M |
| 5 |
AG
Algert Global
San Francisco,
California
|
-$11.3M |
